Publication number: 20260015339
Abstract: A calix[4]arenes of the formula (1a), wherein: Y1, Y2, Y3 and Y4 are selected from hydrogen, halogen, NO2, N3, CN, CHO, COOR?, CONR?2, NR2, triazole moiety and C1-C3-alkyl group, the C1-C3-alkyl group being optionally substituted, Z is a heterocyclic moiety which is selected from the group including of imidazole, benzimidazole, benzothiazole, benzoxazole, purine, tetrazine, oxazole, pyrazole and thiazole, the heterocyclic moiety being optionally substituted, R1 and R2 are selected from hydrogen and C1-C8-alkyl, the C1-C8-alkyl group being optionally substituted, n being an integer between 1 and 4, They exhibit high cytotoxicity against cancer cells.
Type:
Application
Filed:
January 25, 2024
Publication date:
January 15, 2026
Applicants:
UNIVERSITE GRENOBLE ALPES, UNIVERSITE LIBRE DE BRUXELLES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE HOSPITALIER REGIONAL DE GRENOBLE, Commissariat à l'Energie Atomique et aux Energies Alternatives
Inventors:
Benoît BUSSER, Aurélien DENIAUD, Pierre LELIEVRE, Lucie SANCEY GALLIOT, Nathan RENIER, Elisabeth H. VALKENIER-VAN DIJK, Ivan JABIN